Skip to main content

Table 1 The basic clinic-pathological features of OvCa patients in two datasets

From: Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico

CharacteristicsnCases (%)
GSE49997GSE9891
Histologic subtype
 Serous435171 (88.1%)264 (92.6%)
 Non-serous4423 (11.9%)21 (7.4%)
FIGO stage
 Stage 1240 (0%)24 (8.4%)
 Stage 2279 (4.6%)18 (6.3%)
 Stage 3371154 (79.4%)217 (76.1%)
 Stage 45331 (16.0%)22 (7.7%)
 Unknown40 (0%)4 (1.4%)
Grade
 Grade 13011 (5.7%)19 (6.7%)
 Grade 213639 (20.1%)97 (34.0%)
 Grade 3307143 (73.7%)164 (57.5%)
 Unknown61 (0.5%)5 (1.8%)
Residual tumor
 No221137 (70.6%)84 (29.5%)
 Yes22157 (29.4%)164 (57.5%)
 Unknown370 (0%)37 (13.0%)